|
6 Companies |
|
10 Products |
|
10 Products |
|
12 Mechanisms of Action |
|
0 Trials |
|
160 News |
|
| 1234» |
- | davunetide intranasal (AL-108) / Endo
Phase classification: Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (clinicaltrials.gov) - Apr 20, 2019
P1, N=12, Completed, Sponsor: University of California, San Francisco
Phase classification: P2 --> P1
- | Trial completion: Aphasia Rehabilitation: Modulating Cues, Feedback & Practice (clinicaltrials.gov) - Nov 30, 2018
P=N/A, N=16, Completed, Sponsor: Shirley Ryan AbilityLab
Phase classification: P2 --> P1 Active, not recruiting --> Completed
- | Trial completion: Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia (clinicaltrials.gov) - Aug 8, 2018
P2, N=52, Completed, Sponsor: Lawson Health Research Institute
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion, Phase classification: Efficacy of Voice Treatment for Parkinson's Disease (clinicaltrials.gov) - Aug 1, 2018
P=N/A, N=620, Completed, Sponsor: University of Colorado, Boulder
Recruiting --> Completed Recruiting --> Completed | Phase classification: P2 --> PN/A
- | Trial completion, Phase classification, Enrollment change: Treatment for Word Retrieval Impairments in Aphasia (clinicaltrials.gov) - Apr 7, 2018
P=N/A, N=24, Completed, Sponsor: Old Dominion University
Recruiting --> Completed | Phase classification: P2 --> PN/A Recruiting --> Completed | Phase classification: P1 --> PN/A | N=16 --> 24
- | Phase classification, Enrollment change: Living With Frontotemporal Dementia (clinicaltrials.gov) - Apr 6, 2018
P, N=16, Terminated, Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting --> Completed | Phase classification: P1 --> PN/A | N=16 --> 24 Phase classification: P=N/A --> P | N=40 --> 16
- | davunetide intranasal (AL-108) / Endo
Trial completion: Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (clinicaltrials.gov) - Mar 26, 2018
P2, N=12, Completed, Sponsor: University of California, San Francisco
Phase classification: P=N/A --> P | N=40 --> 16 Active, not recruiting --> Completed
- | Enrollment change, Trial primary completion date: Computerised Therapy in Chronic Stroke (clinicaltrials.gov) - Jan 10, 2018
P=N/A, N=7, Completed, Sponsor: Cambridge University Hospitals NHS Foundation Trust
Active, not recruiting --> Completed N=40 --> 7 | Trial primary completion date: Jan 2015 --> May 2015
- | Phase classification, Enrollment change: Multimodal Treatment of Phonological Alexia: Behavioral & fMRI Outcomes (clinicaltrials.gov) - Nov 30, 2017
P=N/A, N=5, Completed, Sponsor: VA Office of Research and Development
N=40 --> 7 | Trial primary completion date: Jan 2015 --> May 2015 Phase classification: P1/2 --> P=N/A | N=18 --> 5
- | Enrollment closed: Aphasia Rehabilitation: Modulating Cues, Feedback & Practice (clinicaltrials.gov) - Oct 17, 2017
P=N/A, N=16, Active, not recruiting, Sponsor: Shirley Ryan AbilityLab
Phase classification: P1/2 --> P=N/A | N=18 --> 5 Recruiting --> Active, not recruiting
- | Trial completion: Treatment Efficacy for Developmental Motor Speech Disorders (clinicaltrials.gov) - Sep 29, 2017
P=N/A, N=45, Completed, Sponsor: The Prompt Institute
Recruiting --> Active, not recruiting Recruiting --> Completed
- | Trial completion, Enrollment change: Cognitive Therapy to Improve Word Finding (clinicaltrials.gov) - Sep 19, 2017
P=N/A, N=78, Completed, Sponsor: Georgetown University
Recruiting --> Completed Recruiting --> Completed | N=40 --> 78
- | Phase classification: Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia (clinicaltrials.gov) - Aug 31, 2017
P=N/A, N=28, Completed, Sponsor: VA Office of Research and Development
Recruiting --> Completed | N=40 --> 78 Phase classification: P2 --> P=N/A
- | Trial completion, Phase classification, Enrollment change: An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia (clinicaltrials.gov) - Aug 21, 2017
P=N/A, N=60, Completed, Sponsor: Kessler Foundation
Phase classification: P2 --> P=N/A Active, not recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=105 --> 60
- | amantadine / Generic mfg.
Enrollment change, Trial withdrawal: Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD) (clinicaltrials.gov) - Aug 14, 2017
P4, N=0, Withdrawn, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed | Phase classification: P1/2 --> PN/A | N=105 --> 60 N=52 --> 0 | Terminated --> Withdrawn
- | Phase classification: Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia (clinicaltrials.gov) - Jul 6, 2017
P=N/A, N=38, Completed, Sponsor: Georgetown University
N=52 --> 0 | Terminated --> Withdrawn Phase classification: P2 --> P=N/A
- | Trial completion: Study of Brain Activity During Speech Production and Speech Perception (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=411, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Phase classification: P2 --> P=N/A Recruiting --> Completed
- | Trial completion: Characteristics of Idiopathic Familial Speech Disorders (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=375, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: Treatment Study of Frontotemporal Dementia (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=20, Completed, Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Dopamine Function in Developmental Stuttering (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=12, Completed, Sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial primary completion date: Aphasia Rehabilitation: Modulating Cues, Feedback & Practice (clinicaltrials.gov) - May 15, 2017
P=N/A, N=16, Recruiting, Sponsor: Rehabilitation Institute of Chicago
Active, not recruiting --> Completed Trial primary completion date: Dec 2016 --> Sep 2017
- | Trial completion: Transcranial Direct Current Stimulation and Aphasia Language Therapy (clinicaltrials.gov) - May 15, 2017
P1, N=12, Completed, Sponsor: Rehabilitation Institute of Chicago
Trial primary completion date: Dec 2016 --> Sep 2017 Active, not recruiting --> Completed
- | Trial completion, Trial primary completion date: ProsKuopio: Computational Tools for Early Diagnosis of Memory Disorders (clinicaltrials.gov) - May 3, 2017
P=N/A, N=126, Completed, Sponsor: University of Eastern Finland
Active, not recruiting --> Completed Enrolling by invitation --> Completed | Trial primary completion date: Jun 2016 --> Apr 2017
- Trial completion, Trial primary completion date: Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering (clinicaltrials.gov) - Jan 31, 2017
P=N/A, N=30, Completed, Sponsor: University of Oxford
Enrolling by invitation --> Completed | Trial primary completion date: Jun 2016 --> Apr 2017 Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Mar 2016
- Trial completion, Enrollment change, Trial primary completion date: Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects (clinicaltrials.gov) - Dec 16, 2016
P1, N=16, Completed, Sponsor: Molecular NeuroImaging
Active, not recruiting --> Completed | Trial primary completion date: Oct 2016 --> Mar 2016 Recruiting --> Completed | N=80 --> 16 | Trial primary completion date: Dec 2016 --> Aug 2016
- Zolinza (vorinostat) / Merck (MSD)
Trial completion, Enrollment change, Trial primary completion date: Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1 (clinicaltrials.gov) - Dec 15, 2016
P1/2, N=12, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting --> Completed | N=80 --> 16 | Trial primary completion date: Dec 2016 --> Aug 2016 Recruiting --> Completed | N=15 --> 12 | Trial primary completion date: Jun 2017 --> Dec 2016
- davunetide intranasal (AL-108) / Endo
Trial primary completion date: Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (clinicaltrials.gov) - Dec 7, 2016
P2, N=12, Active, not recruiting, Sponsor: University of California, San Francisco
Recruiting --> Completed | N=15 --> 12 | Trial primary completion date: Jun 2017 --> Dec 2016 Trial primary completion date: Jul 2016 --> Jul 2017
- Trial completion, Trial primary completion date: Intensive Dysarthria Sessions in Adults and Children With Down Syndrome (clinicaltrials.gov) - Nov 23, 2016
P=N/A, N=5, Completed, Sponsor: Duke University
Trial primary completion date: Jul 2016 --> Jul 2017 Active, not recruiting --> Completed | Trial primary completion date: Nov 2016 --> May 2016
- Trial completion: Brain Mechanisms Underlying Reading Improvement in Central Alexia (clinicaltrials.gov) - Nov 4, 2016
P=N/A, N=23, Completed, Sponsor: University College, London
Active, not recruiting --> Completed | Trial primary completion date: Nov 2016 --> May 2016 Active, not recruiting --> Completed
- | Trial completion: Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia (clinicaltrials.gov) - Oct 18, 2016
P=N/A, N=12, Completed, Sponsor: Scion NeuroStim
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial primary completion date: Treatment Efficacy for Developmental Motor Speech Disorders (clinicaltrials.gov) - Sep 28, 2016
P=N/A, N=44, Recruiting, Sponsor: The Prompt Institute
Active, not recruiting --> Completed Trial primary completion date: Dec 2016 --> Apr 2017
- Trial completion, Trial primary completion date: Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells (clinicaltrials.gov) - Jun 23, 2016
P1/2, N=25, Completed, Sponsor: Children's Hospital Los Angeles
Trial primary completion date: Dec 2016 --> Apr 2017 Recruiting --> Completed | Trial primary completion date: Aug 2012 --> Aug 2015
- Enrollment closed, Trial primary completion date: Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering (clinicaltrials.gov) - May 20, 2016
P=N/A, N=30, Active, not recruiting, Sponsor: University of Oxford
Recruiting --> Completed | Trial primary completion date: Aug 2012 --> Aug 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2016 --> Oct 2016
- Trial completion: Auditory Masking Effects on Speech Fluency in Aphasia and Apraxia of Speech (clinicaltrials.gov) - May 12, 2016
P=N/A, N=46, Completed, Sponsor: University of North Carolina, Chapel Hill
Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2016 --> Oct 2016 Recruiting --> Completed
- Trial primary completion date: Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia (clinicaltrials.gov) - Apr 15, 2016
P=N/A, N=12, Active, not recruiting, Sponsor: Scion NeuroStim
Recruiting --> Completed Trial primary completion date: Mar 2016 --> Jun 2016
- ||||||| LMTX (hydromethylthionine) / TauRx
Trial completion, Trial initiation date: Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) (clinicaltrials.gov) - Apr 11, 2016
P3, N=220, Completed, Sponsor: TauRx Therapeutics Ltd
Trial primary completion date: Mar 2016 --> Jun 2016 Active, not recruiting --> Completed | Initiation date: Aug 2013 --> May 2013
- Trial primary completion date: Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects (clinicaltrials.gov) - Apr 9, 2016
P1, N=80, Recruiting, Sponsor: Molecular NeuroImaging
Active, not recruiting --> Completed | Initiation date: Aug 2013 --> May 2013 Trial primary completion date: Feb 2016 --> Dec 2016
- Enrollment closed, Trial primary completion date: Brain Mechanisms Underlying Reading Improvement in Central Alexia (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=23, Active, not recruiting, Sponsor: University College, London
Trial primary completion date: Feb 2016 --> Dec 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Jul 2016
- Trial primary completion date: Aphasia Rehabilitation: Modulating Cues, Feedback & Practice (clinicaltrials.gov) - Mar 21, 2016
P=N/A, N=16, Recruiting, Sponsor: Rehabilitation Institute of Chicago
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Jul 2016 Trial primary completion date: Aug 2016 --> Dec 2016
- Trial primary completion date: Transcranial Direct Current Stimulation and Aphasia Language Therapy (clinicaltrials.gov) - Mar 21, 2016
P1, N=12, Active, not recruiting, Sponsor: Rehabilitation Institute of Chicago
Trial primary completion date: Aug 2016 --> Dec 2016 Trial primary completion date: Dec 2015 --> Dec 2016
- Trial termination: Living With Frontotemporal Dementia (clinicaltrials.gov) - Feb 29, 2016
P=N/A, N=40, Terminated, Sponsor: National Human Genome Research Institute (NHGRI)
Trial primary completion date: Dec 2015 --> Dec 2016 Recruiting --> Terminated
- Enrollment closed, Trial primary completion date: Effects of Neuromodulation on Verbal Fluency in Post-stroke Aphasia (clinicaltrials.gov) - Feb 9, 2016
P=N/A, N=12, Active, not recruiting, Sponsor: Scion NeuroStim
Recruiting --> Terminated Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016
- Trial completion, Enrollment change, Trial primary completion date, HEOR: Posterior Fossa Mutism on Quality of Life (clinicaltrials.gov) - Feb 5, 2016
P=N/A, N=24, Completed, Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2015 --> Mar 2016 Recruiting --> Completed | N=60 --> 24 | Trial primary completion date: Mar 2015 --> Mar 2012
- Enrollment closed, Enrollment change, Trial primary completion date: Intensive Dysarthria Sessions in Adults and Children With Down Syndrome (clinicaltrials.gov) - Feb 3, 2016
P=N/A, N=3, Active, not recruiting, Sponsor: Duke University
Recruiting --> Completed | N=60 --> 24 | Trial primary completion date: Mar 2015 --> Mar 2012 Recruiting --> Active, not recruiting | N=12 --> 3 | Trial primary completion date: Nov 2015 --> Nov 2016
- davunetide intranasal (AL-108) / Endo
Trial primary completion date: Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (clinicaltrials.gov) - Jan 28, 2016
P2, N=12, Active, not recruiting, Sponsor: University of California, San Francisco
Recruiting --> Active, not recruiting | N=12 --> 3 | Trial primary completion date: Nov 2015 --> Nov 2016 Trial primary completion date: Dec 2015 --> Jul 2016
- Enrollment change, Trial withdrawal, Trial primary completion date: A Composite MR Neuroimaging Marker for Alzheimer's Disease (clinicaltrials.gov) - Jan 15, 2016
P=N/A, N=0, Withdrawn, Sponsor: Medical College of Wisconsin
Trial primary completion date: Dec 2015 --> Jul 2016 N=380 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Mar 2014 --> Jan 2016
- Phase classification: PiB PET Scanning in Speech and Language Based Dementias (clinicaltrials.gov) - Dec 23, 2015
P1, N=168, Completed, Sponsor: Mayo Clinic
N=380 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Mar 2014 --> Jan 2016 Phase classification: P=N/A --> P1
- Phase classification: Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD (clinicaltrials.gov) - Dec 21, 2015
P1, N=27, Completed, Sponsor: Mayo Clinic
Phase classification: P=N/A --> P1 Phase classification: P=N/A --> P1
- Enrollment open: ProsKuopio: Computational Tools for Early Diagnosis of Memory Disorders (clinicaltrials.gov) - Dec 15, 2015
P=N/A, N=120, Enrolling by invitation, Sponsor: University of Eastern Finland
Phase classification: P=N/A --> P1 Active, not recruiting --> Enrolling by invitation
- Enrollment change, Trial termination, Trial primary completion date: Living With Aphasia: An International Study (clinicaltrials.gov) - Dec 10, 2015
P=N/A, N=15, Terminated, Sponsor: New York University School of Medicine
Active, not recruiting --> Enrolling by invitation N=204 --> 15 | Recruiting --> Terminated | Trial primary completion date: Dec 2017 --> May 2012; Funding stopped